Technical Analysis for TSVT - 2seventy bio, Inc.

Grade Last Price % Change Price Change
B 29.95 15.82% 4.09
TSVT closed up 15.82 percent on Tuesday, December 7, 2021, on 1.29 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical TSVT trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 15.82%
Hot IPO Pullback Bullish Swing Setup 15.82%
New 52 Week Low Weakness 15.82%
Wide Bands Range Expansion 15.82%
Oversold Stochastic Weakness 15.82%
Inside Day Range Contraction 10.39%
Stochastic Buy Signal Bullish 5.72%
Older End-of-Day Signals for TSVT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR about 15 hours ago
60 Minute Opening Range Breakout about 15 hours ago
Hot IPO Pullback Entry about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Rose Above 10 DMA about 15 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
Classification

Sector: Healthcare
Industry: Drug Manufacturers-General
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell

Is TSVT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 44.34
52 Week Low 24.9
Average Volume 471,093
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 32.92
10-Day Moving Average 28.27
Average True Range 4.00
ADX 0.0
+DI 16.96
-DI 21.41
Chandelier Exit (Long, 3 ATRs) 32.34
Chandelier Exit (Short, 3 ATRs) 36.90
Upper Bollinger Bands 43.37
Lower Bollinger Band 22.46
Percent B (%b) 0.36
BandWidth 63.51
MACD Line -3.60
MACD Signal Line -2.80
MACD Histogram -0.8068
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.01
Resistance 3 (R3) 37.59 34.48 36.66
Resistance 2 (R2) 34.48 32.43 34.69 36.21
Resistance 1 (R1) 32.22 31.16 33.35 32.64 35.77
Pivot Point 29.11 29.11 29.68 29.32 29.11
Support 1 (S1) 26.85 27.06 27.98 27.27 24.13
Support 2 (S2) 23.74 25.79 23.95 23.69
Support 3 (S3) 21.48 23.74 23.24
Support 4 (S4) 21.90